Mark J. Alles

2013

In 2013, Mark J. Alles earned a total compensation of $7.5M as President and Chief Operating Officer at Celgene, a 102% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,188,449
Option Awards$2,440,484
Salary$666,667
Stock Awards$1,186,586
Other$20,511
Total$7,502,697

Alles received $3.2M in non-equity incentive plan, accounting for 42% of the total pay in 2013.

Alles also received $2.4M in option awards, $666.7K in salary, $1.2M in stock awards and $20.5K in other compensation.

Rankings

In 2013, Mark J. Alles' compensation ranked 711th out of 12,286 executives tracked by ExecPay. In other words, Alles earned more than 94.2% of executives.

ClassificationRankingPercentile
All
711
out of 12,286
94th
Division
Manufacturing
231
out of 4,612
95th
Major group
Chemicals And Allied Products
58
out of 1,466
96th
Industry group
Drugs
36
out of 1,160
97th
Industry
Pharmaceutical Preparations
33
out of 890
96th
Source: SEC filing on April 28, 2016.

Alles' colleagues

We found four more compensation records of executives who worked with Mark J. Alles at Celgene in 2013.

2013

Robert Hugin

Celgene

Chief Executive Officer

2013

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2013

Thomas Daniel

Celgene

Chairman

2013

Perry Karsen

Celgene

Chief Executive Officer

You may also like